Extracellular	B:C3894683
vesicles	I:C3894683
from	O
bone	O
marrow	I:C0005953
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
protect	O
against	O
murine	O
hepatic	O
ischemia	I:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Extracellular	O
vesicles	I:C3894683
from	O
bone	B:C0005953
marrow	I:C0005953
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
protect	O
against	O
murine	O
hepatic	O
ischemia	I:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Extracellular	O
vesicles	I:C3894683
from	O
bone	O
marrow	I:C0005953
derived	O
mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
protect	O
against	O
murine	O
hepatic	O
ischemia	I:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Extracellular	O
vesicles	I:C3894683
from	O
bone	O
marrow	I:C0005953
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
protect	O
against	O
murine	B:C0026809
hepatic	O
ischemia	I:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Extracellular	O
vesicles	I:C3894683
from	O
bone	O
marrow	I:C0005953
derived	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
protect	O
against	O
murine	O
hepatic	B:C4303160
ischemia	I:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Hepatic	B:C4303160
ischemia	I:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
(	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
)	O
and	O
associated	O
inflammation	I:C0021368
contributes	O
to	O
liver	O
dysfunction	I:C0086565
and	O
complications	O
after	O
liver	O
surgery	I:C0193373
and	O
transplantation	O
.	O

Hepatic	O
ischemia	I:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
(	O
ischemia	B:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
)	O
and	O
associated	O
inflammation	I:C0021368
contributes	O
to	O
liver	O
dysfunction	I:C0086565
and	O
complications	O
after	O
liver	O
surgery	I:C0193373
and	O
transplantation	O
.	O

Hepatic	O
ischemia	I:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
(	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
)	O
and	O
associated	B:C0021368
inflammation	I:C0021368
contributes	O
to	O
liver	O
dysfunction	I:C0086565
and	O
complications	O
after	O
liver	O
surgery	I:C0193373
and	O
transplantation	O
.	O

Hepatic	O
ischemia	I:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
(	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
)	O
and	O
associated	O
inflammation	I:C0021368
contributes	O
to	O
liver	B:C0086565
dysfunction	I:C0086565
and	O
complications	O
after	O
liver	O
surgery	I:C0193373
and	O
transplantation	O
.	O

Hepatic	O
ischemia	I:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
(	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
)	O
and	O
associated	O
inflammation	I:C0021368
contributes	O
to	O
liver	O
dysfunction	I:C0086565
and	O
complications	B:C0009566
after	O
liver	O
surgery	I:C0193373
and	O
transplantation	O
.	O

Hepatic	O
ischemia	I:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
(	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
)	O
and	O
associated	O
inflammation	I:C0021368
contributes	O
to	O
liver	O
dysfunction	I:C0086565
and	O
complications	O
after	O
liver	B:C0193373
surgery	I:C0193373
and	O
transplantation	O
.	O

Hepatic	O
ischemia	I:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
(	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
)	O
and	O
associated	O
inflammation	I:C0021368
contributes	O
to	O
liver	O
dysfunction	I:C0086565
and	O
complications	O
after	O
liver	O
surgery	I:C0193373
and	O
transplantation	B:C0040732
.	O

Mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
(	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
)	O
have	O
been	O
reported	O
to	O
reduce	O
hepatic	O
IRI	I:C4303160
because	O
of	O
their	O
reparative	O
immunomodulatory	O
effects	O
in	O
injured	O
tissues	O
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
Mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
)	O
have	O
been	O
reported	O
to	O
reduce	O
hepatic	O
IRI	I:C4303160
because	O
of	O
their	O
reparative	O
immunomodulatory	O
effects	O
in	O
injured	O
tissues	O
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
)	O
have	O
been	O
reported	O
to	O
reduce	O
hepatic	B:C4303160
IRI	I:C4303160
because	O
of	O
their	O
reparative	O
immunomodulatory	O
effects	O
in	O
injured	O
tissues	O
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
)	O
have	O
been	O
reported	O
to	O
reduce	O
hepatic	O
IRI	I:C4303160
because	O
of	O
their	O
reparative	O
immunomodulatory	B:C1527392
effects	O
in	O
injured	O
tissues	O
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
)	O
have	O
been	O
reported	O
to	O
reduce	O
hepatic	O
IRI	I:C4303160
because	O
of	O
their	O
reparative	O
immunomodulatory	O
effects	O
in	O
injured	O
tissues	B:C0040300
.	O

Recent	O
studies	O
have	O
highlighted	O
beneficial	O
effects	O
of	O
extracellular	B:C3894683
vesicles	I:C3894683
from	O
MSCs	O
(	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
)	O
on	O
tissue	O
injury	O
.	O

Recent	O
studies	O
have	O
highlighted	O
beneficial	O
effects	O
of	O
extracellular	O
vesicles	I:C3894683
from	O
MSCs	B:C1257975
(	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
)	O
on	O
tissue	O
injury	O
.	O

Recent	O
studies	O
have	O
highlighted	O
beneficial	O
effects	O
of	O
extracellular	O
vesicles	I:C3894683
from	O
MSCs	O
(	O
Mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
)	O
on	O
tissue	O
injury	O
.	O

Recent	O
studies	O
have	O
highlighted	O
beneficial	O
effects	O
of	O
extracellular	O
vesicles	I:C3894683
from	O
MSCs	O
(	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	B:C3894683
)	O
on	O
tissue	O
injury	O
.	O

The	O
effects	O
of	O
systemically	O
administered	O
mouse	B:C1511243
bone	I:C1511243
marrow	I:C1511243
derived	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
were	O
evaluated	O
in	O
an	O
experimental	O
murine	I:C0887965
model	I:C0887965
of	O
hepatic	O
IRI	I:C4303160
induced	O
by	O
cross	O
clamping	O
the	O
hepatic	O
artery	I:C0019145
and	O
portal	O
vein	I:C0032718
for	O
90	O
minutes	O
followed	O
by	O
reperfusion	O
for	O
periods	O
of	O
upto	O
6	O
hours	O
.	O

The	O
effects	O
of	O
systemically	O
administered	O
mouse	O
bone	I:C1511243
marrow	I:C1511243
derived	O
Mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
were	O
evaluated	O
in	O
an	O
experimental	O
murine	I:C0887965
model	I:C0887965
of	O
hepatic	O
IRI	I:C4303160
induced	O
by	O
cross	O
clamping	O
the	O
hepatic	O
artery	I:C0019145
and	O
portal	O
vein	I:C0032718
for	O
90	O
minutes	O
followed	O
by	O
reperfusion	O
for	O
periods	O
of	O
upto	O
6	O
hours	O
.	O

The	O
effects	O
of	O
systemically	O
administered	O
mouse	O
bone	I:C1511243
marrow	I:C1511243
derived	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	B:C3894683
were	O
evaluated	O
in	O
an	O
experimental	O
murine	I:C0887965
model	I:C0887965
of	O
hepatic	O
IRI	I:C4303160
induced	O
by	O
cross	O
clamping	O
the	O
hepatic	O
artery	I:C0019145
and	O
portal	O
vein	I:C0032718
for	O
90	O
minutes	O
followed	O
by	O
reperfusion	O
for	O
periods	O
of	O
upto	O
6	O
hours	O
.	O

The	O
effects	O
of	O
systemically	O
administered	O
mouse	O
bone	I:C1511243
marrow	I:C1511243
derived	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
were	O
evaluated	O
in	O
an	O
experimental	B:C0887965
murine	I:C0887965
model	I:C0887965
of	O
hepatic	O
IRI	I:C4303160
induced	O
by	O
cross	O
clamping	O
the	O
hepatic	O
artery	I:C0019145
and	O
portal	O
vein	I:C0032718
for	O
90	O
minutes	O
followed	O
by	O
reperfusion	O
for	O
periods	O
of	O
upto	O
6	O
hours	O
.	O

The	O
effects	O
of	O
systemically	O
administered	O
mouse	O
bone	I:C1511243
marrow	I:C1511243
derived	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
were	O
evaluated	O
in	O
an	O
experimental	O
murine	I:C0887965
model	I:C0887965
of	O
hepatic	B:C4303160
IRI	I:C4303160
induced	O
by	O
cross	O
clamping	O
the	O
hepatic	O
artery	I:C0019145
and	O
portal	O
vein	I:C0032718
for	O
90	O
minutes	O
followed	O
by	O
reperfusion	O
for	O
periods	O
of	O
upto	O
6	O
hours	O
.	O

The	O
effects	O
of	O
systemically	O
administered	O
mouse	O
bone	I:C1511243
marrow	I:C1511243
derived	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
were	O
evaluated	O
in	O
an	O
experimental	O
murine	I:C0887965
model	I:C0887965
of	O
hepatic	O
IRI	I:C4303160
induced	O
by	O
cross	O
clamping	O
the	O
hepatic	B:C0019145
artery	I:C0019145
and	O
portal	O
vein	I:C0032718
for	O
90	O
minutes	O
followed	O
by	O
reperfusion	O
for	O
periods	O
of	O
upto	O
6	O
hours	O
.	O

The	O
effects	O
of	O
systemically	O
administered	O
mouse	O
bone	I:C1511243
marrow	I:C1511243
derived	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
were	O
evaluated	O
in	O
an	O
experimental	O
murine	I:C0887965
model	I:C0887965
of	O
hepatic	O
IRI	I:C4303160
induced	O
by	O
cross	O
clamping	O
the	O
hepatic	O
artery	I:C0019145
and	O
portal	B:C0032718
vein	I:C0032718
for	O
90	O
minutes	O
followed	O
by	O
reperfusion	O
for	O
periods	O
of	O
upto	O
6	O
hours	O
.	O

The	O
effects	O
of	O
systemically	O
administered	O
mouse	O
bone	I:C1511243
marrow	I:C1511243
derived	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
were	O
evaluated	O
in	O
an	O
experimental	O
murine	I:C0887965
model	I:C0887965
of	O
hepatic	O
IRI	I:C4303160
induced	O
by	O
cross	O
clamping	O
the	O
hepatic	O
artery	I:C0019145
and	O
portal	O
vein	I:C0032718
for	O
90	O
minutes	O
followed	O
by	O
reperfusion	B:C0035124
for	O
periods	O
of	O
upto	O
6	O
hours	O
.	O

Compared	O
with	O
controls	B:C0013125
,	I:C0013125
intravenous	I:C0013125
administration	I:C0013125
of	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
30	O
minutes	O
prior	O
to	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
dramatically	O
reduced	O
the	O
extent	O
of	O
tissue	O
necrosis	I:C0027540
,	O
decreased	O
caspase	O
-	I:C0291573
3	I:C0291573
positive	I:C0291573
and	O
apoptotic	O
cells	I:C3269134
,	O
and	O
reduced	O
serum	O
aminotransferase	O
levels	O
.	O

Compared	O
with	O
controls	O
,	I:C0013125
intravenous	I:C0013125
administration	I:C0013125
of	O
Mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
30	O
minutes	O
prior	O
to	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
dramatically	O
reduced	O
the	O
extent	O
of	O
tissue	O
necrosis	I:C0027540
,	O
decreased	O
caspase	O
-	I:C0291573
3	I:C0291573
positive	I:C0291573
and	O
apoptotic	O
cells	I:C3269134
,	O
and	O
reduced	O
serum	O
aminotransferase	O
levels	O
.	O

Compared	O
with	O
controls	O
,	I:C0013125
intravenous	I:C0013125
administration	I:C0013125
of	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	B:C3894683
30	O
minutes	O
prior	O
to	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
dramatically	O
reduced	O
the	O
extent	O
of	O
tissue	O
necrosis	I:C0027540
,	O
decreased	O
caspase	O
-	I:C0291573
3	I:C0291573
positive	I:C0291573
and	O
apoptotic	O
cells	I:C3269134
,	O
and	O
reduced	O
serum	O
aminotransferase	O
levels	O
.	O

Compared	O
with	O
controls	O
,	I:C0013125
intravenous	I:C0013125
administration	I:C0013125
of	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
30	O
minutes	O
prior	O
to	O
ischemia	B:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
dramatically	O
reduced	O
the	O
extent	O
of	O
tissue	O
necrosis	I:C0027540
,	O
decreased	O
caspase	O
-	I:C0291573
3	I:C0291573
positive	I:C0291573
and	O
apoptotic	O
cells	I:C3269134
,	O
and	O
reduced	O
serum	O
aminotransferase	O
levels	O
.	O

Compared	O
with	O
controls	O
,	I:C0013125
intravenous	I:C0013125
administration	I:C0013125
of	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
30	O
minutes	O
prior	O
to	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
dramatically	O
reduced	O
the	O
extent	O
of	O
tissue	B:C0027540
necrosis	I:C0027540
,	O
decreased	O
caspase	O
-	I:C0291573
3	I:C0291573
positive	I:C0291573
and	O
apoptotic	O
cells	I:C3269134
,	O
and	O
reduced	O
serum	O
aminotransferase	O
levels	O
.	O

Compared	O
with	O
controls	O
,	I:C0013125
intravenous	I:C0013125
administration	I:C0013125
of	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
30	O
minutes	O
prior	O
to	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
dramatically	O
reduced	O
the	O
extent	O
of	O
tissue	O
necrosis	I:C0027540
,	O
decreased	O
caspase	B:C0291573
-	I:C0291573
3	I:C0291573
positive	I:C0291573
and	O
apoptotic	O
cells	I:C3269134
,	O
and	O
reduced	O
serum	O
aminotransferase	O
levels	O
.	O

Compared	O
with	O
controls	O
,	I:C0013125
intravenous	I:C0013125
administration	I:C0013125
of	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
30	O
minutes	O
prior	O
to	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
dramatically	O
reduced	O
the	O
extent	O
of	O
tissue	O
necrosis	I:C0027540
,	O
decreased	O
caspase	O
-	I:C0291573
3	I:C0291573
positive	I:C0291573
and	O
apoptotic	B:C3269134
cells	I:C3269134
,	O
and	O
reduced	O
serum	O
aminotransferase	O
levels	O
.	O

Compared	O
with	O
controls	O
,	I:C0013125
intravenous	I:C0013125
administration	I:C0013125
of	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
30	O
minutes	O
prior	O
to	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
dramatically	O
reduced	O
the	O
extent	O
of	O
tissue	O
necrosis	I:C0027540
,	O
decreased	O
caspase	O
-	I:C0291573
3	I:C0291573
positive	I:C0291573
and	O
apoptotic	O
cells	I:C3269134
,	O
and	O
reduced	O
serum	O
aminotransferase	B:C0002594
levels	O
.	O

Mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
hepatic	O
mRNA	O
expression	I:C1515670
of	O
NACHT	O
,	I:C1864814
LRR	I:C1864814
and	I:C1864814
PYD	I:C1864814
domains	I:C1864814
-	I:C1864814
containing	I:C1864814
protein	I:C1864814
12	I:C1864814
(	O
Nlrp12	O
)	O
,	O
and	O
the	O
chemokine	O
(	I:C0812445
C	I:C0812445
-	I:C0812445
X	I:C0812445
-	I:C0812445
C	I:C0812445
motif	I:C0812445
)	I:C0812445
ligand	I:C0812445
1	I:C0812445
(	O
CXCL1	O
)	O
,	O
and	O
reduced	O
mRNA	O
expression	I:C1515670
of	O
several	O
inflammatory	O
cytokines	O
such	O
as	O
IL	O
-	I:C0021760
6	I:C0021760
during	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	B:C3894683
increased	O
hepatic	O
mRNA	O
expression	I:C1515670
of	O
NACHT	O
,	I:C1864814
LRR	I:C1864814
and	I:C1864814
PYD	I:C1864814
domains	I:C1864814
-	I:C1864814
containing	I:C1864814
protein	I:C1864814
12	I:C1864814
(	O
Nlrp12	O
)	O
,	O
and	O
the	O
chemokine	O
(	I:C0812445
C	I:C0812445
-	I:C0812445
X	I:C0812445
-	I:C0812445
C	I:C0812445
motif	I:C0812445
)	I:C0812445
ligand	I:C0812445
1	I:C0812445
(	O
CXCL1	O
)	O
,	O
and	O
reduced	O
mRNA	O
expression	I:C1515670
of	O
several	O
inflammatory	O
cytokines	O
such	O
as	O
IL	O
-	I:C0021760
6	I:C0021760
during	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
hepatic	B:C0205054
mRNA	O
expression	I:C1515670
of	O
NACHT	O
,	I:C1864814
LRR	I:C1864814
and	I:C1864814
PYD	I:C1864814
domains	I:C1864814
-	I:C1864814
containing	I:C1864814
protein	I:C1864814
12	I:C1864814
(	O
Nlrp12	O
)	O
,	O
and	O
the	O
chemokine	O
(	I:C0812445
C	I:C0812445
-	I:C0812445
X	I:C0812445
-	I:C0812445
C	I:C0812445
motif	I:C0812445
)	I:C0812445
ligand	I:C0812445
1	I:C0812445
(	O
CXCL1	O
)	O
,	O
and	O
reduced	O
mRNA	O
expression	I:C1515670
of	O
several	O
inflammatory	O
cytokines	O
such	O
as	O
IL	O
-	I:C0021760
6	I:C0021760
during	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
hepatic	O
mRNA	B:C1515670
expression	I:C1515670
of	O
NACHT	O
,	I:C1864814
LRR	I:C1864814
and	I:C1864814
PYD	I:C1864814
domains	I:C1864814
-	I:C1864814
containing	I:C1864814
protein	I:C1864814
12	I:C1864814
(	O
Nlrp12	O
)	O
,	O
and	O
the	O
chemokine	O
(	I:C0812445
C	I:C0812445
-	I:C0812445
X	I:C0812445
-	I:C0812445
C	I:C0812445
motif	I:C0812445
)	I:C0812445
ligand	I:C0812445
1	I:C0812445
(	O
CXCL1	O
)	O
,	O
and	O
reduced	O
mRNA	O
expression	I:C1515670
of	O
several	O
inflammatory	O
cytokines	O
such	O
as	O
IL	O
-	I:C0021760
6	I:C0021760
during	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
hepatic	O
mRNA	O
expression	I:C1515670
of	O
NACHT	B:C1864814
,	I:C1864814
LRR	I:C1864814
and	I:C1864814
PYD	I:C1864814
domains	I:C1864814
-	I:C1864814
containing	I:C1864814
protein	I:C1864814
12	I:C1864814
(	O
Nlrp12	O
)	O
,	O
and	O
the	O
chemokine	O
(	I:C0812445
C	I:C0812445
-	I:C0812445
X	I:C0812445
-	I:C0812445
C	I:C0812445
motif	I:C0812445
)	I:C0812445
ligand	I:C0812445
1	I:C0812445
(	O
CXCL1	O
)	O
,	O
and	O
reduced	O
mRNA	O
expression	I:C1515670
of	O
several	O
inflammatory	O
cytokines	O
such	O
as	O
IL	O
-	I:C0021760
6	I:C0021760
during	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
hepatic	O
mRNA	O
expression	I:C1515670
of	O
NACHT	O
,	I:C1864814
LRR	I:C1864814
and	I:C1864814
PYD	I:C1864814
domains	I:C1864814
-	I:C1864814
containing	I:C1864814
protein	I:C1864814
12	I:C1864814
(	O
Nlrp12	B:C1864814
)	O
,	O
and	O
the	O
chemokine	O
(	I:C0812445
C	I:C0812445
-	I:C0812445
X	I:C0812445
-	I:C0812445
C	I:C0812445
motif	I:C0812445
)	I:C0812445
ligand	I:C0812445
1	I:C0812445
(	O
CXCL1	O
)	O
,	O
and	O
reduced	O
mRNA	O
expression	I:C1515670
of	O
several	O
inflammatory	O
cytokines	O
such	O
as	O
IL	O
-	I:C0021760
6	I:C0021760
during	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
hepatic	O
mRNA	O
expression	I:C1515670
of	O
NACHT	O
,	I:C1864814
LRR	I:C1864814
and	I:C1864814
PYD	I:C1864814
domains	I:C1864814
-	I:C1864814
containing	I:C1864814
protein	I:C1864814
12	I:C1864814
(	O
Nlrp12	O
)	O
,	O
and	O
the	O
chemokine	B:C0812445
(	I:C0812445
C	I:C0812445
-	I:C0812445
X	I:C0812445
-	I:C0812445
C	I:C0812445
motif	I:C0812445
)	I:C0812445
ligand	I:C0812445
1	I:C0812445
(	O
CXCL1	O
)	O
,	O
and	O
reduced	O
mRNA	O
expression	I:C1515670
of	O
several	O
inflammatory	O
cytokines	O
such	O
as	O
IL	O
-	I:C0021760
6	I:C0021760
during	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
hepatic	O
mRNA	O
expression	I:C1515670
of	O
NACHT	O
,	I:C1864814
LRR	I:C1864814
and	I:C1864814
PYD	I:C1864814
domains	I:C1864814
-	I:C1864814
containing	I:C1864814
protein	I:C1864814
12	I:C1864814
(	O
Nlrp12	O
)	O
,	O
and	O
the	O
chemokine	O
(	I:C0812445
C	I:C0812445
-	I:C0812445
X	I:C0812445
-	I:C0812445
C	I:C0812445
motif	I:C0812445
)	I:C0812445
ligand	I:C0812445
1	I:C0812445
(	O
CXCL1	B:C0812445
)	O
,	O
and	O
reduced	O
mRNA	O
expression	I:C1515670
of	O
several	O
inflammatory	O
cytokines	O
such	O
as	O
IL	O
-	I:C0021760
6	I:C0021760
during	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
hepatic	O
mRNA	O
expression	I:C1515670
of	O
NACHT	O
,	I:C1864814
LRR	I:C1864814
and	I:C1864814
PYD	I:C1864814
domains	I:C1864814
-	I:C1864814
containing	I:C1864814
protein	I:C1864814
12	I:C1864814
(	O
Nlrp12	O
)	O
,	O
and	O
the	O
chemokine	O
(	I:C0812445
C	I:C0812445
-	I:C0812445
X	I:C0812445
-	I:C0812445
C	I:C0812445
motif	I:C0812445
)	I:C0812445
ligand	I:C0812445
1	I:C0812445
(	O
CXCL1	O
)	O
,	O
and	O
reduced	O
mRNA	B:C1515670
expression	I:C1515670
of	O
several	O
inflammatory	O
cytokines	O
such	O
as	O
IL	O
-	I:C0021760
6	I:C0021760
during	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
hepatic	O
mRNA	O
expression	I:C1515670
of	O
NACHT	O
,	I:C1864814
LRR	I:C1864814
and	I:C1864814
PYD	I:C1864814
domains	I:C1864814
-	I:C1864814
containing	I:C1864814
protein	I:C1864814
12	I:C1864814
(	O
Nlrp12	O
)	O
,	O
and	O
the	O
chemokine	O
(	I:C0812445
C	I:C0812445
-	I:C0812445
X	I:C0812445
-	I:C0812445
C	I:C0812445
motif	I:C0812445
)	I:C0812445
ligand	I:C0812445
1	I:C0812445
(	O
CXCL1	O
)	O
,	O
and	O
reduced	O
mRNA	O
expression	I:C1515670
of	O
several	O
inflammatory	O
cytokines	B:C0079189
such	O
as	O
IL	O
-	I:C0021760
6	I:C0021760
during	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
hepatic	O
mRNA	O
expression	I:C1515670
of	O
NACHT	O
,	I:C1864814
LRR	I:C1864814
and	I:C1864814
PYD	I:C1864814
domains	I:C1864814
-	I:C1864814
containing	I:C1864814
protein	I:C1864814
12	I:C1864814
(	O
Nlrp12	O
)	O
,	O
and	O
the	O
chemokine	O
(	I:C0812445
C	I:C0812445
-	I:C0812445
X	I:C0812445
-	I:C0812445
C	I:C0812445
motif	I:C0812445
)	I:C0812445
ligand	I:C0812445
1	I:C0812445
(	O
CXCL1	O
)	O
,	O
and	O
reduced	O
mRNA	O
expression	I:C1515670
of	O
several	O
inflammatory	O
cytokines	O
such	O
as	O
IL	B:C0021760
-	I:C0021760
6	I:C0021760
during	O
ischemia	O
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
hepatic	O
mRNA	O
expression	I:C1515670
of	O
NACHT	O
,	I:C1864814
LRR	I:C1864814
and	I:C1864814
PYD	I:C1864814
domains	I:C1864814
-	I:C1864814
containing	I:C1864814
protein	I:C1864814
12	I:C1864814
(	O
Nlrp12	O
)	O
,	O
and	O
the	O
chemokine	O
(	I:C0812445
C	I:C0812445
-	I:C0812445
X	I:C0812445
-	I:C0812445
C	I:C0812445
motif	I:C0812445
)	I:C0812445
ligand	I:C0812445
1	I:C0812445
(	O
CXCL1	O
)	O
,	O
and	O
reduced	O
mRNA	O
expression	I:C1515670
of	O
several	O
inflammatory	O
cytokines	O
such	O
as	O
IL	O
-	I:C0021760
6	I:C0021760
during	O
ischemia	B:C4303160
-	I:C4303160
reperfusion	I:C4303160
injury	I:C4303160
.	O

Mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
cell	O
viability	I:C0007620
and	O
suppressed	O
both	O
oxidative	O
injury	O
and	O
NF	O
-	I:C0961340
κB	I:C0961340
activity	O
in	O
AML12	O
murine	I:C0227525
hepatocytes	I:C0227525
in	O
vitro	O
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	B:C3894683
increased	O
cell	O
viability	I:C0007620
and	O
suppressed	O
both	O
oxidative	O
injury	O
and	O
NF	O
-	I:C0961340
κB	I:C0961340
activity	O
in	O
AML12	O
murine	I:C0227525
hepatocytes	I:C0227525
in	O
vitro	O
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
cell	B:C0007620
viability	I:C0007620
and	O
suppressed	O
both	O
oxidative	O
injury	O
and	O
NF	O
-	I:C0961340
κB	I:C0961340
activity	O
in	O
AML12	O
murine	I:C0227525
hepatocytes	I:C0227525
in	O
vitro	O
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
cell	O
viability	I:C0007620
and	O
suppressed	O
both	O
oxidative	O
injury	O
and	O
NF	B:C0961340
-	I:C0961340
κB	I:C0961340
activity	O
in	O
AML12	O
murine	I:C0227525
hepatocytes	I:C0227525
in	O
vitro	O
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
-	O
EV	O
increased	O
cell	O
viability	I:C0007620
and	O
suppressed	O
both	O
oxidative	O
injury	O
and	O
NF	O
-	I:C0961340
κB	I:C0961340
activity	O
in	O
AML12	B:C0227525
murine	I:C0227525
hepatocytes	I:C0227525
in	O
vitro	O
.	O

In	O
conclusion	O
,	O
the	O
administration	B:C1533734
of	O
EV	O
derived	O
from	O
bone	O
marrow	I:C0005953
derived	O
MSCs	O
may	O
ameliorate	O
hepatic	O
IRI	I:C4303160
by	O
reducing	O
hepatic	O
injury	I:C0160390
through	O
modulation	O
of	O
the	O
inflammatory	O
response	I:C1155266
.	O

In	O
conclusion	O
,	O
the	O
administration	O
of	O
EV	B:C3894683
derived	O
from	O
bone	O
marrow	I:C0005953
derived	O
MSCs	O
may	O
ameliorate	O
hepatic	O
IRI	I:C4303160
by	O
reducing	O
hepatic	O
injury	I:C0160390
through	O
modulation	O
of	O
the	O
inflammatory	O
response	I:C1155266
.	O

In	O
conclusion	O
,	O
the	O
administration	O
of	O
EV	O
derived	O
from	O
bone	B:C0005953
marrow	I:C0005953
derived	O
MSCs	O
may	O
ameliorate	O
hepatic	O
IRI	I:C4303160
by	O
reducing	O
hepatic	O
injury	I:C0160390
through	O
modulation	O
of	O
the	O
inflammatory	O
response	I:C1155266
.	O

In	O
conclusion	O
,	O
the	O
administration	O
of	O
EV	O
derived	O
from	O
bone	O
marrow	I:C0005953
derived	O
MSCs	B:C1257975
may	O
ameliorate	O
hepatic	O
IRI	I:C4303160
by	O
reducing	O
hepatic	O
injury	I:C0160390
through	O
modulation	O
of	O
the	O
inflammatory	O
response	I:C1155266
.	O

In	O
conclusion	O
,	O
the	O
administration	O
of	O
EV	O
derived	O
from	O
bone	O
marrow	I:C0005953
derived	O
MSCs	O
may	O
ameliorate	B:C0243095
hepatic	O
IRI	I:C4303160
by	O
reducing	O
hepatic	O
injury	I:C0160390
through	O
modulation	O
of	O
the	O
inflammatory	O
response	I:C1155266
.	O

In	O
conclusion	O
,	O
the	O
administration	O
of	O
EV	O
derived	O
from	O
bone	O
marrow	I:C0005953
derived	O
MSCs	O
may	O
ameliorate	O
hepatic	B:C4303160
IRI	I:C4303160
by	O
reducing	O
hepatic	O
injury	I:C0160390
through	O
modulation	O
of	O
the	O
inflammatory	O
response	I:C1155266
.	O

In	O
conclusion	O
,	O
the	O
administration	O
of	O
EV	O
derived	O
from	O
bone	O
marrow	I:C0005953
derived	O
MSCs	O
may	O
ameliorate	O
hepatic	O
IRI	I:C4303160
by	O
reducing	O
hepatic	B:C0160390
injury	I:C0160390
through	O
modulation	O
of	O
the	O
inflammatory	O
response	I:C1155266
.	O

In	O
conclusion	O
,	O
the	O
administration	O
of	O
EV	O
derived	O
from	O
bone	O
marrow	I:C0005953
derived	O
MSCs	O
may	O
ameliorate	O
hepatic	O
IRI	I:C4303160
by	O
reducing	O
hepatic	O
injury	I:C0160390
through	O
modulation	B:C0443264
of	O
the	O
inflammatory	O
response	I:C1155266
.	O

In	O
conclusion	O
,	O
the	O
administration	O
of	O
EV	O
derived	O
from	O
bone	O
marrow	I:C0005953
derived	O
MSCs	O
may	O
ameliorate	O
hepatic	O
IRI	I:C4303160
by	O
reducing	O
hepatic	O
injury	I:C0160390
through	O
modulation	O
of	O
the	O
inflammatory	B:C1155266
response	I:C1155266
.	O

